BS-600M

retail price

market price

weights

Quantity

surplus

Add to cart

Buy Now

隐藏域元素占位

Details

Accurate and efficient, accessible by tentacles
Continuous injection into the sample rack,
One touch standing test HbA1c whole blood directly on the machine, with accurate results
Efficient and stable electrolyte detection is complete
Traceable supporting testing system
Biochemical speed: constant speed 600 tests/hour
Flexible sample management
Meet the 24-hour needs of the laboratory
Assist in early reporting of results
Implement humanized interaction
Complete HbA1c detection plan
improve work efficiency
Improving efficiency through whole blood operation; Standardize processing to reduce errors; 120t/h high throughput meets screening requirements.
Ensure testing quality
The whole blood HbA1c detection of Mindray BS-600M adopts a binding enzyme method, which can specifically avoid interference from hemoglobin (Hb) variants (HbS, HbC, HbE, and HbD) and other Hb derivatives (unstable Hb, acylated Hb, and acetylated Hb). Meirui enzyme based glycated hemoglobin detection can achieve accurate results in one measurement, which is efficient and economical.
Lower enzyme detection limit
Predict Hb concentration in the cracking solution, conduct incremental testing in advance, and reduce reagent waste.
Efficient and easy to operate
·Detectable Na+/K+/Cl -
·One tube of sample can simultaneously detect electrolytes and routine biochemical items
·Long life electrode
·Automatic calibration
·Fewer consumables
·Convenient operation and maintenance
High quality measurement system
The Mindray 600M testing system achieves up to 70% of supporting projects with a 6Sigma "World Level" to ensure quality while reducing the amount of quality control products used, thereby saving the total cost of each test and accurately testing each sample.
·Extend the reportable range, solve false negative results in high concentration samples, and improve the accuracy of abnormal sample detection results.
·Prevent hook like effects in immune turbidimetric items from causing false negative results and reduce clinical complaints.
·Control the false negative results caused by the interference of reducing substances in testing items such as glucose and triglycerides, and improve the consistency of testing results with clinical practice.